Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial. - Kekitiinwa AR; Jennings A; Bwakura-Dangarembizi M; Kityo C; Siika A; Archary M; Green A; Jafta L; Akabwai GP; Mujuru HA; Mugerwa H; Kiilu C; et al. (The lancet. HIV, 2026)